614
Participants
Start Date
November 20, 2023
Primary Completion Date
March 3, 2024
Study Completion Date
March 11, 2025
Aptitude Medical Systems Metrix COVID/Flu Test
The Metrix COVID/Flu Test is a real-time reverse transcription loop-mediated isothermal amplification reaction (RT-LAMP) test that has been designed to detect viral RNA from SARS-CoV-2, Influenza A, and Influenza B via electrochemical detection using the Metrix Reader. Detection of SARS-CoV-2 gene targets will produce a positive SARS-CoV-2 result, detection of the Flu A gene target will produce a positive Flu A result, and detection of the Flu B gene target will produce a positive Flu B result. If no target is detected and the internal control amplifies, the result is negative. If no amplification is detected in any of the channels, an invalid result is displayed.
American Family Care, Trussville
Central Coast Laboratories, Goleta
American Family Care, Chelmsford
Lead Sponsor
Biomedical Advanced Research and Development Authority
FED
Aptitude Medical Systems
INDUSTRY